Whitehawk Therapeutics (WHWK) Return on Capital Employed Growth (3y) (2014 - 2026)
Whitehawk Therapeutics (WHWK) Return on Capital Employed Growth (3y) (2014 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 65,839.48 Bn | 65,839.20 Bn | - | - |
| 2 | Nanobiotix | 1,914.07 Bn | 1,914.01 Bn | - | - |
| 3 | Akari Therapeutics | 1,009.43 Bn | 1,009.43 Bn | - | - |
| 4 | BeOne Medicines | 469.68 Bn | 464.89 Bn | 1.35 Bn | 4,893.00 |
| 5 | Vertex Pharmaceuticals | 122.76 Bn | 115.51 Bn | 2.59 Bn | -494.00 |
| 6 | Regeneron Pharmaceuticals | 70.40 Bn | 61.65 Bn | 3.31 Bn | -649.00 |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - | - |
| 8 | Argenx Se | 55.88 Bn | 50.69 Bn | 1.41 Bn | - |
| 9 | Alnylam Pharmaceuticals | 37.53 Bn | 34.52 Bn | 959.66 Mn | 4,853.00 |
| 10 | Whitehawk Therapeutics | 256.18 Mn | 44.92 Mn | - | -5,475.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -5,475.00 |
| Dec 31, 2025 | -4,242.00 |
| Sep 30, 2025 | -2,209.00 |
| Jun 30, 2025 | 5,870.00 |
| Mar 31, 2025 | 4,211.00 |
| Dec 31, 2024 | -3,559.00 |
| Sep 30, 2024 | 984.00 |
| Jun 30, 2024 | -7,793.00 |
| Mar 31, 2024 | -11,240.00 |
| Dec 31, 2023 | -32,047.00 |
| Sep 30, 2023 | -5,097.00 |
| Jun 30, 2023 | -3,328.00 |
| Mar 31, 2023 | 1,494.00 |
| Dec 31, 2022 | 2,523.00 |
| Sep 30, 2022 | 2,114.00 |
| Jun 30, 2022 | -8,459.00 |
| Mar 31, 2022 | -6,472.00 |
| Dec 31, 2021 | -5,699.00 |
| Sep 30, 2021 | -8,191.00 |
| Jun 30, 2021 | 11,378.00 |